E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPDPIV0109(DPP IV-inhibitory peptide)
DFBP ID DFBPDPIV0109
Peptide sequence YPVEPF
Type Native peptide
Peptide/Function name DPP-IV inhibitory peptide, Anti-diabetic peptide
Function-activity relationship
Main bioactivity DPP-IV inhibitory activity
Otheir bioactivity Opioid activity [D1], Multifunctional activity [D2]
Calculated physicochemical properties
Three-letter amino acid Tyr-Pro-Val-Glu-Pro-Phe
Single-letter amino acid YPVEPF
Peptide length 6
Peptide mass
Experimental mass Theoretical mass
N.D 750.84 Da c
Net charge 0.00 c
Isoelectric point (pI) 3.34 c
IC50 N.D
pIC50 N.D
GRAVY -0.1667 c
Hydrophilic residue ratio 66.67% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Bovine milk proteins
Precursor protein β-Casein
Residue position

f(114-119)

Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
DPP IV-inhibitory activity

The peptide showed potent inhibitory activity against Dipeptidyl-peptidase IV (EC 3.4.14.5) with the IC50 value of 124.7 ± 9.1 μM (p < 0.05), and its DPP-IV inhibitory pattern was shown by Lineweaver–Burk plots to be a mixed inhibition pattern. 


Specific target protein(s) Specific Target Protein(s):
Dipeptidyl peptidase 4
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CCC(=O)O)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)O
Preparation method
Mode of preparation

Synthesis

Enzyme(s)/starter culture

The peptides were from Genscript (Piscataway, NJ, USA).

Stability & Cytotoxicity
Peptide stability
Literature report:

The peptide YPVEPF was cleaved by DPP-IV at the C-terminal side of the penultimate P residue and the expected products of this reaction (YP and VEPF) were identified for YPVEP [1].

EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information

Peptides present within the gastrointestinal tract of human may have promise for the development of natural DPP-IV inhibitors for the management of serum glucose.

Database cross-references
DFBP
[D1] DFBPOPIO0101
[D2] DFBPMUFU0728
BIOPEP-UWM [D3] 9252
APD [D4] -
BioPepDB [D5] -
MBPDB [D6] -
Reference(s)
Primary literature Nongonierma AB, FitzGerald RJ. Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity. Peptides. 2016 May;79:1-7.
PMID: 26988873
Other literature(s)

[1] Nongonierma A B, Paolella S, Mudgil P, et al. Identification of novel dipeptidyl peptidase IV (DPP-IV) inhibitory peptides in camel milk protein hydrolysates[J]. Food Chemistry, 2018, 244:340.

PubDate 2016
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214